RPSA
Richard P. Slaughter Associates’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-129,355
| Closed | -$3.43M | – | 150 |
|
2024
Q4 | $3.43M | Sell |
129,355
-8,016
| -6% | -$213K | 0.77% | 29 |
|
2024
Q3 | $3.98M | Sell |
137,371
-19,561
| -12% | -$566K | 0.92% | 24 |
|
2024
Q2 | $4.39M | Buy |
156,932
+10,808
| +7% | +$302K | 1.04% | 22 |
|
2024
Q1 | $4.05M | Buy |
146,124
+37,754
| +35% | +$1.05M | 0.97% | 22 |
|
2023
Q4 | $3.12M | Buy |
108,370
+551
| +0.5% | +$15.9K | 0.77% | 25 |
|
2023
Q3 | $3.58M | Buy |
107,819
+59,821
| +125% | +$1.98M | 0.95% | 19 |
|
2023
Q2 | $1.76M | Buy |
47,998
+3,143
| +7% | +$115K | 0.5% | 55 |
|
2023
Q1 | $1.83M | Buy |
44,855
+1,444
| +3% | +$58.9K | 0.6% | 47 |
|
2022
Q4 | $2.22M | Buy |
43,411
+1,555
| +4% | +$79.7K | 0.7% | 43 |
|
2022
Q3 | $1.83M | Buy |
+41,856
| New | +$1.83M | 0.77% | 42 |
|
2021
Q4 | – | Sell |
-4,789
| Closed | -$205K | – | 130 |
|
2021
Q3 | $205K | Buy |
+4,789
| New | +$205K | 0.08% | 119 |
|